Popular Articles

Prostate Cancer Patient Receives First RapidArc Radiotherapy Treatment At Major Danish Hospital
A leading Danish cancer hospital has treated its first patient using RapidArc(R) radiotherapy after installing eight advanced radiotherapy treatment machines from Varian Medical Systems (NYSE: VAR) of Palo Alto, California. Herlev Hospital, to the north-west of Copenhagen, delivered the fast and efficient RapidArc treatment to a prostate cancer patient using a Clinac(R) iX linear accelerator.
buy viagra
Glutamine Supplements Show Promise In Treating Stomach Ulcers
Nearly 20 years ago, it was discovered that bacteria known as Helicobacter pylori were responsible for stomach ulcers. Since then, antibiotics have become the primary therapy used to combat the H. pylori infection, which affects approximately six percent of the world population and is also a primary cause of stomach cancer. But today the bacteria is growing increasingly resistant to antibiotics.
News of the day
Discovery Of Faulty Genes Could Reveal Risk Of Bone Disease
The discovery of faulty genes by Edinburgh researchers could help people with Paget"s disease, a painful bone condition. Dr Omar Albagha has found three genes associated with the disease which, if detected early enough in people, could hasten diagnosis and treatment.
Health Insurance

British Medical Journal Report Supports SCHS White Paper On Statins

The results of a study published in the current issue of the peer reviewed British Medical Journal (BMJ) support the findings of a white paper released last month by the Senior Center for Health and Security (SCHS) regarding the potentially lifesaving qualities of cholesterol lowering drugs known as statins. The report concluded, "In patients without established cardiovascular disease but with cardiovascular risk factors, statin use was associated with significantly improved survival and large reductions in the risk of major cardiovascular events." A meta-analysis of 10 significant statin trials involving more than 70,000 patients published in the June 30 BMJ show that statins can reduce the risk of death by 12%, reduce coronary events by 30% and cardiovascular events by 19%. Researchers also underscored the potential value of statins to men 65 years of age and older and older women with diabetes and other cardiovascular risk factors noting that, "it is likely that a considerable number of such people would benefit from long-term statin use," wrote the study"s authors, led by Dr. Jasper Brugts of the Erasmus MC Thoraxcenter in Rotterdam, the Netherlands. The BMJ findings parallel those of the June 29 white paper by the SCHS which found that research indicates statin use can not only help patients lower their cholesterol but can have other life saving benefits as well. "More Americans and growing portions of the global medical community are coming to an important consensus on the potential of statins to improve heart health and save lives," said SCHS Policy Director Al Cors. "We"ve been educating seniors on this issue for years and we"re seeing more data and research supporting those efforts. Cors noted the importance of recognizing the many types of statins and how each may play a role in addressing the specific cardiovascular risks for each patient. "Only by talking with their doctor can patients make sure they receive the right statin to meet their cholesterol goals through a well monitored regimen," said Cors. Senior Center for Health and Security


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):